---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-016394"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:37:17.663669+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma appoints Alan L. Urban to Board and Audit Committee

## Summary
- Alan L. Urban appointed to fill vacant Board seat and serve on Audit Committee effective June 9, 2022.
- Board determined Urban qualifies as independent director under Nasdaq rules.
- Urban has 25+ years finance/accounting experience, including CFO at Research Solutions (RSSS) and ReachLocal (RLOC).
- Urban is a CPA (inactive) since 1998; holds B.S. in Accounting from California State University, Northridge.

## SEC filing metadata
- accession: 0001493152-22-016394
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315222016394/0001493152-22-016394-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315222016394/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-016394
- JSON: https://secwatch.observer/filing/0001493152-22-016394.json
- Plain text: https://secwatch.observer/filing/0001493152-22-016394.txt

## Key facts
- Executive change
  Alan L. Urban was appointed as Director at GT Biopharma, Inc..
  - Action: appointed
  - Role: Director
  source text: Effective June 9, 2022, pursuant to the authority granted under the Registrant’s Amended and Restated Bylaws, the Registrant’s Board of Directors (“Board”) appointed Alan L. Urban to fill a vacant seat on the Board and to serve as a member of the Audit Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000149315222016394/0001493152-22-016394-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.